Static Chart BerGenBio ASA

Equities

Real-time Oslo Bors Other stock markets 10:45:00 2024-05-16 EDT			5-day change	1st Jan Change
0.1306 ^NOK	+4.48%		-4.67%	-53.02%

03-20	Bergenbio Announces Initiation of Phase 2A in First Line Non-Small Lung Cancer Patients with A STK11 Mutation	CI
02-14	BerGenBio ASA Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Duration

Period